Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs » Research

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Changes in the Position of Insulin Pumps Significantly Impacts Accuracy Posted: Sunday, January 31, 2010

Researchers have concluded that changing the height of a conventional insulin pump in relation to its tubing and infusion set can significantly impact expected insulin delivery rates.

Novo Nordisk receives US approval for Victoza® Posted: Tuesday, January 26, 2010

Novo Nordisk receives US approval for Victoza® (liraglutide) for the treatment of type 2 diabetes.

JDRF Artificial Pancreas Project Going Forward Posted: Sunday, January 24, 2010

RF forms partnership with Animas to develop first-generation automated system for managing Type 1 diabetes.

Fear of Hypoglycemia in Parents of Children with Type 1 Diabetes Associated with Poor Control Posted: Sunday, January 24, 2010

The association between a higher level of hypoglycemic-related fear and parental emotional distress and poorer glycemic control in the child emphasizes the need for programs to support and guide parents.

New Sensor Could Help Treat, Combat Diabetes, Other Diseases Posted: Thursday, January 21, 2010

A tiny new sensor could provide fresh, inexpensive diagnosis and treatment methods for people suffering from a variety of diseases. University of Florida engineers have designed and tested versions of the sensor for applications ranging from monitoring diabetics’ glucose levels via their breath to detecting possible indicators of breast cancer in saliva. They say early results are promising — particularly considering that the sensor can be mass produced inexpensively with technology already widely used for making chips in cell phones and other devices.

Metformin Safe for Patients with Advanced Heart Failure and Diabetes Posted: Sunday, January 17, 2010

A new study has shown that metformin, is safe for use in treating patients who have both diabetes and advanced heart failure.

Andrew P. Mandell - Mr. Diabetes® to Sit On ProtoKinetix Advisory Board Posted: Friday, January 15, 2010

Andrew P. Mandell - Mr. Diabetes®, Executive Director of Defeat Diabetes Foundation and diabetes advocate announced today that he will be sitting on the ProtoKinetix (PKTX) Advisory Board. ProtoKinetix, Inc. is a biotechnology company that has developed and patented a family of synthetic anti-aging glycoproteins (AAGP™) for medicine and the biotechnology and cosmetic industries.

Study Finds the Cause of Blindness from Diabetes Posted: Thursday, January 14, 2010

A Michigan State University scientist has finally discovered how high blood sugar levels can cause blindness.

ProtoKinetix’ AAGP™ Shows Promise as a Tool in Diabetes Treatment / Cure Posted: Tuesday, January 12, 2010

Independent studies done by universities and corporations have illustrated a remarkable increase in the yield of viable stem cells after cryopreservation using AAGP™ in the freeze-thaw process. One future approach to increasing diabetics’ insulin production is related to an ability to convert their stem cells into islet cells for transplantation. The feasibility of this procedure is dependent upon the amount of functioning islet cells that can be derived from the patient’s stem cells. This is where AAGP™ can make a very beneficial contribution.

Diabetes Lowers Protective Effects of HDL Posted: Sunday, January 03, 2010

High-density lipoprotein (HDL), known as "good" cholesterol, isn't as protective for people with Type 2 diabetes, according to new research.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.